MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Search

Quidel Corp

Fechado

14.17 -7.45

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.98

Máximo

15.34

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+100.72% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-193M

1B

Abertura anterior

21.62

Fecho anterior

14.17

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 de abr. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 de abr. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de abr. de 2026, 23:07 UTC

Conversa de Mercado

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 de abr. de 2026, 22:54 UTC

Conversa de Mercado

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 de abr. de 2026, 20:57 UTC

Notícias Principais

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de abr. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 de abr. de 2026, 20:25 UTC

Aquisições, Fusões, Aquisições de Empresas

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de abr. de 2026, 19:30 UTC

Notícias Principais

How Digital Currencies Have Helped Iran -- WSJ

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

100.72% parte superior

Previsão para 12 meses

Média 30.75 USD  100.72%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat